Usage of human stem cells in experimental ischemic disorders
- 作者: Surkov K.G.1,2,3, Belova L.A.1,2,3, Krasnyakov V.K.1,2,3, Karpova N.S.1,2,3
-
隶属关系:
- All-Russian Scientific Center for the Safety of Biologically Active Substances
- St. Petersburg State Healthcare Institution "City Blood Transfusion Station"
- Closed Joint Stock Company "Crionix"
- 期: 卷 2, 编号 2 (2007)
- 页面: 93-93
- 栏目: Reports
- ##submission.dateSubmitted##: 14.02.2023
- ##submission.dateAccepted##: 14.02.2023
- ##submission.datePublished##: 14.02.2023
- URL: https://genescells.ru/2313-1829/article/view/233502
- ID: 233502
如何引用文章
全文:
![受限制的访问](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
作者简介
K. Surkov
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
编辑信件的主要联系方式.
Email: redaktor@celltranspl.ru
俄罗斯联邦, Kupavna Old; Saint Petersburg; Saint Petersburg
L. Belova
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Email: redaktor@celltranspl.ru
俄罗斯联邦, Kupavna Old; Saint Petersburg; Saint Petersburg
V. Krasnyakov
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Email: redaktor@celltranspl.ru
俄罗斯联邦, Kupavna Old; Saint Petersburg; Saint Petersburg
N. Karpova
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Email: redaktor@celltranspl.ru
俄罗斯联邦, Kupavna Old; Saint Petersburg; Saint Petersburg
参考
补充文件
![](/img/style/loading.gif)